Arshad M. Khanani, MD, MA, discusses phase 3 SOL-1 data showing axitinib sustained vision in wet AMD for 9-12 months after 1 ...
Introducing Nicholas Riina, MS. Nicholas Riina, MS, had his eye on the prize early on, growing up in a family in which he was ...
In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Brodie about ...
Bausch + Lomb announced topline results from its phase 2 study of BL1107 in patients with glaucoma. According to the company, the trial did not achieve its primary endpoint of rep ...
Cynthia Toth, MD, of Duke University, discusses new BabySTEPS research showing that retinal nerve fiber layer and choroidal thickness on OCT correlate with 2-year neurodevelopmental outcomes in ...
The first half of 2026 brought a steady drumbeat of regulatory and clinical news across the diabetic eye disease space, from ...
Esen Akpek, MD, on dry eye's emotional and vision-related toll, its hidden autoimmune links, and when to move patients beyond ...
Bedside OCT in preterm infants links retinal thickness to motor, cognition, and autism risk at age 2, hinting at earlier ...
The FDA issued a nationwide recall of a steroid eye drop. The US Food and Drug Administration (FDA) announced a nationwide ...
Alcon and RxSight, Inc have announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting ...
For decades, the management of diabetic retinopathy (DR) has consisted mainly of optimizing metabolic control (blood glucose, pressure and lipids) and routine surveillance as preventive strategies, ...
Pooling data from 317 published articles covering 690 individual patient cases, the review's authors searched PubMed, Scopus and the Cochrane Library for reports of noninfectious uveitis linked to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results